Patent · US Active

Anti-LY6H antibodies and antibody drug conjugates

US11434303B2 · kind B2 · utility

1Cited by

0References

12Claims

0Family size

Assignee

Bluefin BioMedicine, Inc · US

Inventors

Tinglei Gu · Andover, US
Scott Michael Lonning · Westford, US
Nels Eric Pederson · Mansfield, US
Aleksandr Tkachev · Cambridge, US
Klarisa Rikova · Reading, US
Sean A. Beausoleil · Essex, US

Key dates

Filing date	Jun 28, 2018
Grant date	Sep 6, 2022
Priority date	—
Expiry date	Oct 14, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N15/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are anti-lymphocyte antigen 6 complex, locus H (LY6H) antibodies and antibody drug conjugates (ADCs), including compositions and methods of using said antibodies and ADCs.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.